MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial (Q35605418)
Jump to navigation
Jump to search
scientific article published on 17 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |
scientific article published on 17 February 2014 |
Statements
1 reference
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial (English)
1 reference
Piotr Wiland
1 reference
Mariusz Korkosz
1 reference
Frank Behrens
1 reference
Paul P Tak
1 reference
Mikkel Østergaard
1 reference
Rumen Stoilov
1 reference
Thomas W Huizinga
1 reference
Stoyanka Vladeva
1 reference
Juergen Rech
1 reference
Andrea Rubbert-Roth
1 reference
Bo J Ejbjerg
1 reference
Jens Geiseler
1 reference
Julia Fresenius
1 reference
Roman P Korolkiewicz
1 reference
Arndt J Schottelius
1 reference
Harald Burkhardt
1 reference
17 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference